首页> 外文期刊>Journal of Nephropathology >Losartan and magnesium sulfate administration reduce gentamicin-induced nephrotoxicity in rat model
【24h】

Losartan and magnesium sulfate administration reduce gentamicin-induced nephrotoxicity in rat model

机译:氯沙坦和硫酸镁给药可减轻庆大霉素诱导的大鼠肾毒性

获取原文
       

摘要

Background : Nephrotoxicity is the most known side effect of gentamicin. In addition, renin angiotensin system (RAS) plays an important role in the pathogenesis of renal injury and nephrotoxicity. Hypomagnesaemia is other complication of gentamicin. Previous studies reported that magnesium plays an important role in cell enzymatic functions, reducing lipid peroxidation. Objectives : We investigated the role of losartan and magnesium sulfate (MgSO4 ) on gentamicin nephrotoxicity. Materials and Methods : In this study, rats randomly assigned to five groups. The first group, received saline, the second group received gentamicin 80 mg/kg/d, intraperitoneally (ip), and the third group, received a regular dose of losartan, 10 mg/kg/d + gentamicin 80 mg/kg/d. The fourth group received MgSO4 , 80 mg/kg/d + gentamicin 80 mg/kg/d. The fifth group obtained a continuous dose of gentamicin 80 mg/kg/d + losartan 10 mg/kg/d + MgSO4 80 mg/kg/d simultaneously. Nine days after administration of drugs, blood samples were collected from the heart. The level of urea, creatinine (Cr), malondialdehyde (MDA) and nitrite were measured in the animal serum and homogenized kidney tissue. Results : Gentamicin increased serum urea and Cr levels. The administration of losartan and MgSO4 lonely and combination of them, significantly reduced the levels of serum urea and Cr. Losartan alone and combination of losartan and MgSO4 compared with gentamicin, significantly decreased kidney MDA level too. Decrease of kidney nitrite level by gentamicin was compensated by the administration of losartan, MgSO4 alone or their combination. Additionally, losartan and MgSO4 alone and their combination together significantly reduced renal damage. Conclusions : The results of this study indicated that administration of losartan and MgSO4 individually and their combination decreased kidney nephrotoxicity and improved renal function. This effect is probably related to the improvement of antioxidant status and renal blood flow.
机译:背景:肾毒性是庆大霉素最常见的副作用。此外,肾素血管紧张素系统(RAS)在肾损伤和肾毒性的发病机制中起重要作用。低镁血症是庆大霉素的其他并发症。先前的研究报道,镁在细胞酶功能中起重要作用,减少脂质过氧化。目的:我们研究了氯沙坦和硫酸镁(MgSO4)对庆大霉素肾毒性的作用。材料和方法:在本研究中,将大鼠随机分为五组。第一组接受盐水,第二组接受腹膜内(ip)庆大霉素80 mg / kg / d,第三组接受常规剂量的氯沙坦10 mg / kg / d +庆大霉素80 mg / kg / d 。第四组接受80 mg / kg / d的MgSO4 + 80 mg / kg / d的庆大霉素。第五组同时获得连续剂量的庆大霉素80 mg / kg / d +氯沙坦10 mg / kg / d + MgSO4 80 mg / kg / d。给药后九天,从心脏收集血液样本。在动物血清和均质的肾脏组织中测定尿素,肌酐(Cr),丙二醛(MDA)和亚硝酸盐的水平。结果:庆大霉素增加血清尿素和铬水平。单独使用氯沙坦和MgSO4以及将它们组合使用,可显着降低血清尿素和铬的水平。与庆大霉素相比,单独使用氯沙坦以及氯沙坦和MgSO4的组合也显着降低了肾脏的MDA水平。庆大霉素对肾脏亚硝酸盐水平的降低可以通过单独服用氯沙坦,MgSO4或它们的组合来补偿。此外,单独使用氯沙坦和硫酸镁及其组合可显着降低肾脏损害。结论:本研究结果表明,单独使用氯沙坦和MgSO4及其组合可降低肾脏肾毒性并改善肾功能。此作用可能与抗氧化剂状态和肾血流量的改善有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号